Literature DB >> 16832669

Temporal lobe resections.

William Harkness1.   

Abstract

INTRODUCTION: In the 50 years since Penfield outlined the requirements of the epilepsy surgeon, we have seen the introduction of the digitised electroencephalogram (EEG), video telemetry and the magnetic resonance imaging (MRI) scan. In the operating room, advances in neuro-anaesthesia, the introduction of the operating microscope, image guidance and the ultrasonic aspirator have greatly enhanced the surgeons' technical ability. Despite these changes, the thesis encapsulated in Penfield's statement is that the surgeon needs to understand and interpret the preoperative data in such a way as to identify as closely as possible the epileptogenic zone where he must carry out surgery with the utmost care and diligence, and finally, in the context of audit and follow-up of his surgical patients, he must be able to predict for each individual case the likelihood of success and failure of any particular procedure.
CONCLUSION: Previous articles in this supplement have looked at the specific investigations carried out to identify the epileptogenic zone, but once this data has been gathered, it is the responsibility of the neurosurgeon, within the context of the multidisciplinary team, to decide whether surgery is both feasible and advisable and then to discuss this in depth with the patient and their family and carers. The multidisciplinary epilepsy surgery meeting allows cases to be discussed in an open forum and the decisions made in this meeting can then be discussed with the family. The process of consent will begin from the moment any surgical procedure is discussed and should, wherever possible, be reinforced with written, as well as verbal, information. The process of consent should be a continuum until the actual day of surgery. All parties involved in the care and management of the patient should be regarded as stakeholders in this decision, and it is vital that all these stakeholders are working towards a common goal.
OBJECTIVES: In this article, I will consider the specific aspects of the presurgical investigations that are applicable to the temporal lobe and the differing types of surgery that are likely to be indicated. I will then describe, in detail, the surgical technique of temporal lobe resection, highlighting some of the pitfalls and successes that such surgery can provide.

Entities:  

Mesh:

Year:  2006        PMID: 16832669     DOI: 10.1007/s00381-006-0140-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  33 in total

1.  Microsurgical anatomy of the temporal lobe: part 1: mesial temporal lobe anatomy and its vascular relationships as applied to amygdalohippocampectomy.

Authors:  H T Wen; A L Rhoton; E de Oliveira; A C Cardoso; H Tedeschi; M Baccanelli; R Marino
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

2.  Neuronavigation and complication rate in epilepsy surgery.

Authors:  Joachim Oertel; Michael Robert Gaab; Uwe Runge; Henry Werner Siegfried Schroeder; Wolfgang Wagner; Jürgen Piek
Journal:  Neurosurg Rev       Date:  2004-03-27       Impact factor: 3.042

3.  Long-term outcome after surgical treatment of temporal lobe epilepsy in children.

Authors:  Sandeep Mittal; José L Montes; Jean-Pierre Farmer; Bernard Rosenblatt; François Dubeau; Frederick Andermann; Nicole Poulin; André Olivier
Journal:  J Neurosurg       Date:  2005-11       Impact factor: 5.115

Review 4.  Temporal lobe epilepsy surgery in childhood: rationale for greater use.

Authors:  W T Blume
Journal:  Can J Neurol Sci       Date:  1997-05       Impact factor: 2.104

5.  Language-related cognitive declines after left temporal lobectomy in children.

Authors:  D J Dlugos; E M Moss; A C Duhaime; A R Brooks-Kayal
Journal:  Pediatr Neurol       Date:  1999-07       Impact factor: 3.372

6.  Surgically amenable epilepsies in children and adolescents: clinical, imaging, electrophysiological, and post-surgical outcome data.

Authors:  Vera C Terra-Bustamante; Regina M F Fernandes; Luciana M Inuzuka; Tonicarlo R Velasco; Veriano Alexandre; Lauro Wichert-Ana; Sandra Funayama; Eliana Garzon; Antonio C Santos; David Araujo; Roger Walz; João A Assirati; Helio R Machado; Américo C Sakamoto
Journal:  Childs Nerv Syst       Date:  2005-05-19       Impact factor: 1.475

7.  Pre- and postoperative neuropsychological profiles in children and adolescents with temporal lobe epilepsy.

Authors:  M Lendt; C Helmstaedter; C E Elger
Journal:  Epilepsia       Date:  1999-11       Impact factor: 5.864

8.  Transparahippocampal selective amygdalohippocampectomy in children and adolescents: efficacy of the procedure and cognitive morbidity in patients.

Authors:  S Robinson; T S Park; L B Blackburn; B F Bourgeois; S T Arnold; W E Dodson
Journal:  J Neurosurg       Date:  2000-09       Impact factor: 5.115

9.  Seizure outcome after temporal lobectomy in temporal lobe cortical dysplasia.

Authors:  Teeradej Srikijvilaikul; Imad M Najm; Collin A Hovinga; Richard A Prayson; Jorge Gonzalez-Martinez; William E Bingaman
Journal:  Epilepsia       Date:  2003-11       Impact factor: 5.864

10.  Pathology of temporal lobectomy for refractory seizures in children. Review of 20 cases including some unique malformative lesions.

Authors:  V Jay; L E Becker; H Otsubo; P A Hwang; H J Hoffman; D Harwood-Nash
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

View more
  2 in total

Review 1.  Temporal lobe resective surgery for medically intractable epilepsy: a review of complications and side effects.

Authors:  Iordanis Georgiadis; Effie Z Kapsalaki; Kostas N Fountas
Journal:  Epilepsy Res Treat       Date:  2013-10-31

2.  Long-term seizure outcome following resective surgery for epilepsy: to be or not to be completely cured?

Authors:  Takeharu Kunieda; Nobuhiro Mikuni; Sumiya Shibata; Rika Inano; Yukihiro Yamao; Takayuki Kikuchi; Riki Matsumoto; Jun Takahashi; Akio Ikeda; Hidenao Fukuyama; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-21       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.